Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton London Docklands Riverside Hotel

Oct 02, 2013 9:00 AM - Oct 02, 2013 12:30 PM

265 Rotherhithe Street , London, SE16 5HW, United Kingdom

Dose Finding in Drug Development: Challenges and Solution

Speakers

Bjoern  Bornkamp, PhD, MSc

Bjoern Bornkamp, PhD, MSc

Senior Director, Statistical Methodology, Novartis Pharma AG, Switzerland

Björn Bornkamp works in the Statistical Methodology Group at Novartis in Basel, where he provides consulting to statisticians and clinical teams on topics related to dose-finding, subgroup analyses, Bayesian statistics as well as estimands and causal inference.

Byron  Jones

Byron Jones

Executive Director, Statistical Methodology and Consulting Group, Novartis Pharma AG, Switzerland

Professor Byron Jones is a Senior Biometrical Fellow and Executive Director in the Statistical Methodology and Consulting Group at Novartis Pharma AG in Basel, Switzerland. He is a Visiting Professor in the Department of Health Sciences, University of Leicester and a Visiting Professorial Fellow in the School of Mathematics at Queen Mary College, University of London. For the 25 years before joining the pharmaceutical industry, he worked in academia, ultimately holding the position of Professor of Medical Statistics at De Montfort University. He is the joint author of four statistical textbooks and over 110 peer-reviewed publications. He serves on several University Advisory Boards including Oxford University's Department of Statistics.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.